Selected article for: "antiviral activity and feIFN Ïb"
Author: Wang, Xiaona; Li, Fengsai; Han, Meijing; Jia, Shuo; Wang, Li; Qiao, Xinyuan; Jiang, Yanping; Cui, Wen; Tang, Lijie; Li, Yijing; Xu, Yi-Gang
Title: Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-? Proteins
  • Document date: 2020_3_19
    • ID: 1me7ugkg_33
    Snippet: Next, we wanted to investigate whether the antiviral activities of the recombinant feIFN-ωa and feIFN-ωb proteins were also broad-spectrum. We performed MCIAs using a wide range of different viruses, including VSV, FCoV, CPV, BVDV, and PEDV. As shown in Figure 7 , rfeIFN-ωa and rfeIFN-ωb both displayed in vitro antiviral activity against VSV, FCoV, CPV, BVDV, and PEDV. Their antiviral activities were especially strong against FCoV and VSV. In.....
    Document: Next, we wanted to investigate whether the antiviral activities of the recombinant feIFN-ωa and feIFN-ωb proteins were also broad-spectrum. We performed MCIAs using a wide range of different viruses, including VSV, FCoV, CPV, BVDV, and PEDV. As shown in Figure 7 , rfeIFN-ωa and rfeIFN-ωb both displayed in vitro antiviral activity against VSV, FCoV, CPV, BVDV, and PEDV. Their antiviral activities were especially strong against FCoV and VSV. In contrast, the antiviral activity of rfeIFN-ωb against FCoV and VSV was significantly stronger than that of rfeIFN-ωa. No notable differences were observed between rfeIFN-ωa and rfeIFN-ωb with CPV, BVDV, or PEDV. In addition, the antiviral activity of rfeIFN-ωb against FCoV and VSV was significantly stronger than that of INTERCAT IFN, and the antiviral activities of both rfeIFN-ωa and rfeIFN-ωb against CPV, BVDV, and PEDV were significantly higher than that of INTERCAT IFN. In fact, we observed no antiviral activity against BVDV or PEDV by INTERCAT IFN. Unsurprisingly, there was no antiviral activity detected in cells' control groups (cells untreated with the IFNs).

    Search related documents:
    Co phrase search for related documents
    • antiviral activity and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and different virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and feIFN ωb protein: 1
    • antiviral activity and feifn recombinant ωa: 1, 2, 3, 4, 5, 6, 7, 8
    • antiviral activity and feifn recombinant ωa antiviral activity: 1, 2, 3, 4, 5
    • antiviral activity and INTERCAT IFN PEDV BVDV antiviral activity: 1, 2
    • antiviral activity and PEDV BVDV antiviral activity: 1, 2, 3, 4
    • antiviral activity and rfeifn ωa: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral activity and rfeifn ωb antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8
    • antiviral activity and rfeIFN ωb rfeifn ωa: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • broad spectrum and different virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • broad spectrum and feIFN ωb protein: 1
    • broad spectrum and feifn recombinant ωa: 1, 2, 3, 4, 5
    • broad spectrum and feifn recombinant ωa antiviral activity: 1, 2, 3
    • broad spectrum and INTERCAT IFN PEDV BVDV antiviral activity: 1, 2
    • broad spectrum and PEDV BVDV antiviral activity: 1, 2, 3, 4
    • broad spectrum and rfeifn ωa: 1, 2, 3, 4, 5
    • broad spectrum and rfeifn ωb antiviral activity: 1, 2, 3, 4
    • broad spectrum and rfeIFN ωb rfeifn ωa: 1, 2, 3, 4